Monday, December 10, 2012

The Cost of Pharmaceutical Facilities



By Dr. Scott Rudge

How many of you are trying to scratch up the coin to give your kids a pharmaceutical facility this Christmas?  Yeah, me neither.  But I had a recent project that required me to come up with an estimate for facility costs, if only to calculate the cost of ownership for a Contract Manufacturing Organization.  This can be an important aspect of the cost of goods, as someone has to pay for the construction, operation and maintenance of a pharmaceutical plant. 

As you might expect, this cost is highly dependent on the type of facility that gets constructed, its purpose, what it was before, and a host of other factors.  Each project is undoubtedly unique but some value can be derived by knowing the range of costs, and some factors that can affect your cost.

For data, I used the Facility of the Year winners in all categories since 2007, when the ISPE/Interphex started to publish this data.  Again, the facilities evaluated in this “category” of facilities are highly divergent in scope and purpose.  Furthermore, to be a winner, it is not necessary to have the most highly finished, modern facility.  There are a few categories, such as Sustainability, Project Integration and Technology that do not focus on the facility itself, but on other aspects that make the project unique.  Here then, is the raw data:



Company
 Cost
 Sq. ft.
 cost/s.f.
purpose
location
Year
Chiesi
 $   117,480,000
236,806
 $ 496.10
R&D Center
Italy
2012
Eisai
 $    41,000,000
2,180,189
 $ 18.81
small molecules
India
2012
Merck
 $   315,000,000
214,000
 $ 1,471.96
vaccines
USA
2012
Rentschler
 $     9,900,000
9,800
 $ 1,010.20
biologics api
Germany
2012
Roche
 $   209,871,400
161,458
 $ 1,299.85
R&D labs
Germany
2012
Irish Government
 $    46,400,000
69,965
 $ 663.19
biologics api
Ireland
2012
MedImmune
 $   588,389,000
337,000
 $ 1,745.96
biologics api
USA
2011
Merck
 $   216,000,000
240,666
 $ 897.51
small molecules
USA
2011
Novartis
 $   242,000,000
257,042
 $ 941.48
vaccines
Germany
2011
Pfizer
 $    42,300,000
173,837
 $ 243.33
small molecules
Germany
2011
Pfizer
 $   188,700,000
54,465
 $ 3,464.61
biologics api
Sweden
2011
Hoffman LaRoche
 $    11,891,102
3,444
 $ 3,452.70
fill/finish
Switzerland
2011
Shire
 $   230,000,000
200,000
 $ 1,150.00
biologics api
USA
2011
Biogen Idec
 $    39,100,000
50,000
 $ 782.00
biologics api
USA
2010
Genentech
 $   194,000,000
102,000
 $ 1,901.96
biologics api
Singapore
2010
MannKind
 $   163,100,000
251,876
 $ 647.54
inhalers
USA
2010
Pfizer
 $   189,613,542
133,000
 $ 1,425.67
biologics api
Ireland
2010
Pfizer
 $   254,674,792
177,066
 $ 1,438.30
fill/finish
Ireland
2010
Aseptic Technologies
 $     4,980,000
12,917
 $ 385.54
fill/finish
Belgium
2009
Centocor
 $   586,000,000
264,000
 $ 2,219.70
biologics api
Ireland
2009
Centocor
 $    24,900,000
7,219
 $ 3,449.23
fill/finish
Switzerland
2009
hameln
 $    44,500,000
99,028
 $ 449.37
fill/finish
Germany
2009
Orchid
 $    35,720,000
107,642
 $ 331.84
small molecules
India
2009
Roche
 $   370,000,000
209,896
 $ 1,762.78
biologics api
Switzerland
2009
GSK
 $     6,300,000
150,695
 $ 41.81
fill/finish
Italy
2009
Pfizer
 $    55,000,000
83,958
 $ 655.09
solids
Germany
2008
BI
 $    64,700,000
95,357
 $ 678.50
R&D labs
Germany
2008
BMS
 $    90,687,000
132,410
 $ 684.90
solids
USA
2008
IDT Biologika
 $    37,470,000
50,568
 $ 740.98
vaccines
Germany
2008
Hoffman LaRoche
 $   460,000,000
355,209
 $ 1,295.01
biologics api
Germany
2008
Cook
 $    70,000,000
124,000
 $ 564.52
biologics api
USA
2007
Genentech
 $   375,000,000
500,000
 $ 750.00
biologics api
USA
2007
Roche
 $    16,640,000
22,604
 $ 736.15
small molecules
China
2007
Taiyo
 $    38,580,000
126,411
 $ 305.19
fill/finish
Japan
2007
Vetter
 $   134,000,000
172,223
 $ 778.06
fill/finish
Germany
2007

What can we make of this data?  The statistics aren’t incredibly helpful for total cost.  The range of costs are approximately $5MM to $500MM, the median is just under $91MM.  The distribution of data is heavily skewed to the lower budget, as shown below:

 The cost per square foot is a little more normally distributed, with a few outliers above $3000/s.f., but most around the mean of $1111/s.f., as shown below:

Is there inflation in the data, represented by an increasing cost per square foot year over year?  The statistics show an average increase of just over $100/s.f., which would be an inflation rate of 9% against the mean cost.  However, the statistical evidence is very weak and heavily influenced by the two facilities that cost more than $3000/s.f.  The regression is shown below:

Finally, although the country data are interesting, there does not appear to be a great correlation between these data and the location of the facility.  While India does have the absolutely cheapest cost/s.f. for a facility, the next three cheapest are Germany, Italy and Japan.  The only country that sticks out is Switzerland, for its extremely high cost.

The data don’t give a lot of hope for predicting the cost of your facility, they are heavily project dependent.  However, they do suggest a range of costs and budgets that might influence your thinking and cost of goods calculations, at least as a first estimate. 

Thursday, September 13, 2012

Calibration Tolerance




Editor's Note:  Interested reader Ray Nims points out that I forgot to square the terms in my propagation of error calculation below.  I apologize for the misinformation.  The corrected blog follows:

In calibration, there is a lot of focus on using the right standard.  Standards must be NIST traceable, have current calibration certifications, and have been cared for appropriately.  See for example ANSI Z540.1 or ISO 17025.  Less attention is paid to the appropriate accuracy of the standard.  In this short blog, we will discuss the basis for instrument range, instrument tolerance and standard tolerance.

An early example of a calibrated measurement device

The tolerance of a process for variation in a certain parameter should be set in process development.  Ideally, this is done as part of process characterization, where the effect of parameter variation is measured.  Some examples of operating ranges set in process development are temperature ± 2°C, pH ± 0.2 units and conductivity ± 10 mS/cm.  Ranges this tight put some pressure on calibration to be especially accurate.  After all, if your instrument is reporting a measurement right at the limit of the acceptable range, it’s probably very important that the instrument not be inaccurate by very much, if at all.

The National Conference of Standards Laboratories (now known as NCSL International) recommends that instruments be calibrated with an uncertainty of no more than 25% of the acceptable control range.  This means that the tolerance (or uncertainty) for the instruments measuring temperature, pH and conductivity cited above would be ± 0.5°C, ± 0.05 and ± 2.5 mS/cm, respectively.  These are tight tolerances, but are needed to ensure that the process is really within ± 125% of the target range.

But wait, there’s more!  You can only be sure that the measuring instrument is within tolerance if you know that the uncertainty of the standard used to calibrate it.  Even standards are not necessarily 100.00% accurate, are they?  Standards used for calibration also have a known uncertainty, and again NCSL International recommends at least a 4:1 ratio of standard to instrument uncertainty.  So the standard used for the instruments above should have a tolerance of no more than ± 0.125°C, ±0.0125 and ± 0.5125 mS/cm, or 6.25% of the operating range. This uncertainty also carries through to the uncertainty of the measurement.  Taken absolutely, the widest range possible range is ± 131% of the actual or target range.  However, it should not be assumed that uncertainty randomly falls to the extremes of the allowable ranges.  It is more common to perform a propagation of errors calculation.  Here, the squares of the errors are added, and the square root of the sum calculated, as shown below

This gives a more likely range of ±126%. 

There is a bottom up approach sometimes taken in determining calibration tolerances.  In this approach, the capability of the instrument is used to determine the calibration tolerance.  In other words, if the thermometer is claimed to have an accuracy of ± 0.1°C by the manufacturer, then it should be calibrated with a temperature standard with an uncertainty of no more than ± 0.025°C.  This approach has proven increasingly difficult, as modern technology has increased the capabilities of field measurement instruments.  However, the approach is valid, and some leeway exists (up to a tolerance ratio of 1:1). 

Of course, higher tolerance ratios are permitted.  But these general guidelines should help you design your calibration program so that you know you are making quality measurements in your process.